Dr. Richard Darveau, a member of Ondine Biopharma Corporation's Clinical Advisory Board, is the recipient of the 2007 Basic Research in Periodontal Disease Award from the International Association for Dental Research (IADR).Ondine Biopharma Corporation announced on May 7 that Dr. Richard Darveau, a member of its Clinical Advisory Board, is the recipient of the 2007 Basic Research in Periodontal Disease Award from the International Association for Dental Research (IADR). This recognition was awarded for his work exploring the significance of the constant low level of inflammation, present in the healthy periodontium, induced by commensal micro-organisms. Dr. Darveau is also engaged in researching the effect of Periowave(TM) on neutralizing the virulence factors produced by intra-oral bacteria. "Dr. Darveau along with the other esteemed members of our Clinical Advisory Board play a critical role in providing clinical, regulatory and marketing advice to Ondine in support of the commercialization of Periowave(TM)," said Carolyn Cross, President and CEO of Ondine Biopharma. "Ondine wishes to congratulate Dr. Darveau for being recognized by his peers for his outstanding contributions to research in the periodontal field." "I am delighted to be a part of this distinguished board of internationally recognized experts," stated Dr. Lawrence Meskin, Chairman of the Clinical Advisory Board. "Ondine's Periowave(TM) Photodisinfection system is a remarkable new technology that promises to revolutionize the way we treat periodontal diseases." |
 Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2 |